Body Weight Support Harness System in Spinal Muscular Atrophy

Spinal Muscular Atrophy Type II Clinical Trial

Official title:
Exploring the Feasibility and Utility of In-home Body Weight Support Harness System Use in Children Treated for Spinal Muscular Atrophy: a Pilot Study

Status Active, not recruiting

Clinical Trial Summary

The goal of this pilot interventional study is to learn about the use of an in-home harness system in children who have been treated for spinal muscular atrophy. The main questions it aims to answer are: 1. Is the in-home body weight support harness system a feasible option for families to use? 2. Is the in-home body weight support harness system a useful tool for children treated for spinal muscular atrophy? 3. Is the in-home body weight support harness system a safe tool for children treated for spinal muscular atrophy? Participants will be given an in-home body weight support harness system and taught how to use it. Families will document how often and for how long they use the system over 6 months. Children will be given tests of motor function at the beginning, 3-months, and 6-months. At the end of the study, families will be asked to fill out a questionnaire about thier experience using the system.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05715749
Study type	Interventional
Source	Nationwide Children's Hospital
Contact
Status	Active, not recruiting
Phase	N/A
Start date	September 7, 2018
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01302600` - Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.	Phase 2
Not yet recruiting	`NCT06300996` - Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb	N/A
Terminated	`NCT00439569` - Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III	Phase 1/Phase 2
Active, not recruiting	`NCT04042025` - Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi	Phase 3
Completed	`NCT05416034` - Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy	N/A
Enrolling by invitation	`NCT06137612` - Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy
Recruiting	`NCT03709784` - Spinraza in Adult Spinal Muscular Atrophy
Active, not recruiting	`NCT05626855` - Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX	Phase 3